3D011-08 Monotherapy in Subjects With Advanced Solid Tumors

Summary

The purpose of this study is evaluate the the safety, tolerability, pharmacokinetics profiles, and preliminary efficacy of 3D011-08 in subjects with advanced solid tumors.

Timeline

Start

2022-02-24

Primary completion

2023-09-11

Completion

2023-09-11

Outcome

Outcome not reported

Stopped: “Company's decision”

Drugs

Indications